189 related articles for article (PubMed ID: 15545170)
1. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers.
Larsen A; Hovdenak N; Karlsdottir A; Wentzel-Larsen T; Dahl O; Fagerhol MK
Scand J Gastroenterol; 2004 Nov; 39(11):1113-8. PubMed ID: 15545170
[TBL] [Abstract][Full Text] [Related]
2. Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study.
Hille A; Rave-Fränk M; Christiansen H; Herrmann MK; Kertesz T; Hermann RM; Wolff HA; Schirmer M; Hess CF; Ramadori G
Scand J Gastroenterol; 2009; 44(8):939-46. PubMed ID: 19504404
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment.
Hille A; Schmidt-Giese E; Hermann RM; Herrmann MK; Rave-Fränk M; Schirmer M; Christiansen H; Hess CF; Ramadori G
Scand J Gastroenterol; 2008 Jan; 43(1):52-8. PubMed ID: 18938774
[TBL] [Abstract][Full Text] [Related]
4. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.
Larsen A; Bjørge B; Klementsen B; Helgeland L; Wentzel-Larsen T; Fagerhol MK; Hovdenak N; Dahl O
Acta Oncol; 2007; 46(5):639-50. PubMed ID: 17562440
[TBL] [Abstract][Full Text] [Related]
5. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
Joshi S; Lewis SJ; Creanor S; Ayling RM
Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
[TBL] [Abstract][Full Text] [Related]
6. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
Sipponen T; Kärkkäinen P; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
Aliment Pharmacol Ther; 2008 Nov; 28(10):1221-9. PubMed ID: 18752630
[TBL] [Abstract][Full Text] [Related]
7. Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy.
Varela E; Antolín M; Guarner F; Verges R; Giralt J; Malagelada JR
Aliment Pharmacol Ther; 2009 Jul; 30(2):175-85. PubMed ID: 19392859
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and inflammatory faecal markers in collagenous colitis.
Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
Sipponen T; Björkesten CG; Färkkilä M; Nuutinen H; Savilahti E; Kolho KL
Scand J Gastroenterol; 2010 Mar; 45(3):325-31. PubMed ID: 20034360
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.
Lamb CA; Mohiuddin MK; Gicquel J; Neely D; Bergin FG; Hanson JM; Mansfield JC
Br J Surg; 2009 Jun; 96(6):663-74. PubMed ID: 19384912
[TBL] [Abstract][Full Text] [Related]
13. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
14. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
Sugi K; Saitoh O; Hirata I; Katsu K
Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
[TBL] [Abstract][Full Text] [Related]
16. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
18. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.
Lundberg JO; Hellström PM; Fagerhol MK; Weitzberg E; Roseth AG
Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):96-102. PubMed ID: 16265127
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.
Shastri YM; Bergis D; Povse N; Schäfer V; Shastri S; Weindel M; Ackermann H; Stein J
Am J Med; 2008 Dec; 121(12):1099-106. PubMed ID: 19028207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
